Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
60.63B | 57.74B | 61.81B | 56.58B | 50.05B | Gross Profit |
12.66B | 12.22B | 11.79B | 9.78B | 10.06B | EBIT |
1.31B | 708.00M | 94.00M | -2.23B | -1.02B | EBITDA |
1.77B | 1.25B | 227.00M | -1.59B | -671.00M | Net Income Common Stockholders |
1.11B | 769.00M | -282.00M | -2.02B | -1.12B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.32B | 3.44B | 3.33B | 4.53B | 3.88B | Total Assets |
47.21B | 48.55B | 47.12B | 47.05B | 44.67B | Total Debt |
5.73B | 6.77B | 9.26B | 10.37B | 4.15B | Net Debt |
1.41B | 3.33B | 5.93B | 5.84B | 273.00M | Total Liabilities |
16.94B | 18.27B | 19.25B | 17.90B | 13.27B | Stockholders Equity |
30.27B | 30.29B | 27.87B | 29.14B | 31.40B |
Cash Flow | Free Cash Flow | |||
2.46B | 2.60B | -1.70B | -5.49B | -1.05B | Operating Cash Flow |
2.62B | 3.72B | -1.33B | -5.17B | -630.00M | Investing Cash Flow |
314.00M | -1.16B | 1.57B | -118.00M | -111.00M | Financing Cash Flow |
-1.96B | -2.81B | -1.36B | 5.73B | 1.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥13.12B | 9.06 | 4.09% | 4.45% | 16.11% | ||
74 Outperform | ¥14.60B | 17.71 | 2.22% | -4.57% | 38.87% | ||
74 Outperform | ¥13.58B | 12.49 | 2.59% | 5.02% | 46.75% | ||
66 Neutral | ¥11.76B | 13.04 | 5.27% | 1.05% | 5.32% | ||
62 Neutral | $6.76B | 11.07 | 2.80% | 6.34% | 2.68% | -24.87% | |
59 Neutral | ¥15.64B | 28.94 | 1.79% | -0.13% | -103.88% | ||
46 Neutral | ¥14.32B | ― | ― | 36.83% | -164.22% |